![Brian Stal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Stal
Direktor/Vorstandsmitglied bei
Imidomics, Inc.
Profil
Brian Stal is currently Director at Imidomics, Inc. and Director of GSD at DNS Capital LLC since 2019.
Formerly, Mr. Stal was Principal at The Pritzker Organization LLC from 2013 to 2022 and Board Member at Greycastle Holdings Ltd. from 2014 to 2018.
Education includes an undergraduate degree from the University of Wisconsin in 2003 and an MBA from The University of Chicago Booth School of Business in 2008.
Aktive Positionen von Brian Stal
| Unternehmen | Position | Beginn |
|---|---|---|
DNS Capital LLC
 DNS Capital LLC Investment ManagersFinance DNS Capital invests in middle market companies located in the United States with an EBITDA of USD 10 - 50 million. The firm focuses on a board range of sectors and industries. It provides financing for early and later stage capital requirements with an investment size ranging from USD 25 - 100 million and acquire minority stakes. | Private Equity Investor | 01.06.2019 |
Imidomics, Inc.
 Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Brian Stal
| Unternehmen | Position | Ende |
|---|---|---|
The Pritzker Organization LLC
 The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization invests in companies located in the United States with an enterprise value of USD 100 - 1000 billion and an EBITDA of USD 10 - 150 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size of USD 75 -300 million for majority deals & USD 15 - 100 million for minority and structured deals. The firm also acquires majority and minority interest. | Private Equity Investor | 31.12.2022 |
Greycastle Holdings Ltd.
 Greycastle Holdings Ltd. Financial ConglomeratesFinance Operates as an investment holding company | Direktor/Vorstandsmitglied | 30.04.2018 |
Ausbildung von Brian Stal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
95
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pritzker Organization LLC
The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization invests in companies located in the United States with an enterprise value of USD 100 - 1000 billion and an EBITDA of USD 10 - 150 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size of USD 75 -300 million for majority deals & USD 15 - 100 million for minority and structured deals. The firm also acquires majority and minority interest. | Finance |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greycastle Holdings Ltd.
Greycastle Holdings Ltd. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
DNS Capital LLC
DNS Capital LLC Investment ManagersFinance DNS Capital invests in middle market companies located in the United States with an EBITDA of USD 10 - 50 million. The firm focuses on a board range of sectors and industries. It provides financing for early and later stage capital requirements with an investment size ranging from USD 25 - 100 million and acquire minority stakes. | Finance |
Imidomics, Inc.
Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Commercial Services |
Wählen Sie MarketScreener 
